Risk Stratification of Acute Coronary Syndrome Patients. A Multi‐Marker Approach

References

• Hamm C. W., Braunwald E. A classification of unstable angina revisited. Circulation 2000; 102: 118–22
   PubMed Web of Science ®Google Scholar
• Falk E. Coronary thrombosis: pathogenesis and clinical manifestations (Review). Am J Cardiol 1991 Sep 3; 68((7))28B–35B
   Google Scholar
• Recommended strategy in ACS without persistent ST segment elevation. Guidelines. Eur Heart J 2002; 23: 1809–40
   PubMed Web of Science ®Google Scholar
• ACC/AHA 2002 Guideline Update for the Management of Patients With Unstable Angina and Non‐ST‐Segment Elevation Myocardial Infarction www.acc.org//www.americanheart.org.
   Google Scholar
• Alpert J., Thygesen K., Antman E., Bassand J. P. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959–69
   PubMed Web of Science ®Google Scholar
• Invasive compared with non‐invasive treatment in unstable coronary‐artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999; 354((9180))708–15
   PubMedGoogle Scholar
• Cannon C. P., Weintraub W. S., Demopoulos L. A., Robertson D. H., Gormley G. J., Braunwald E. Invasive versus conservative strategies in unstable angina and non‐Q‐wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS‐TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction. Am J Cardiol 1998; 82: 731–6
   PubMedGoogle Scholar
• Management of acute myocardial infarction in patients presenting with ST‐segment elevation. Guidelines. Eur Society of Cardiology: EHJ 2003;24:28–66. and ACC/AHA 2004 www.acc.org//www.americanheart.org.
   Google Scholar
• Morrow D. A., De lemos J. A., Sabatine M. S. Evaluation of B‐type natriuretic peptide for risk assessment in unstable angina/non‐ST elevation MI: BNP and prognosis in TACTICS‐TIMI 18. J Am Coll Cardiol 2003; 41: 1264–1272
   PubMed Web of Science ®Google Scholar
• Lindahl B., Toss H., Siegbahn A. Markers of myocardial damage and inflammation in relation to long‐term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343: 1139–47
   PubMed Web of Science ®Google Scholar
• James S. K., Armstrong P., Barnathan E. Troponin and C‐reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO‐IV substudy. J Am Coll Cardiol 2003; 41: 916–24
   PubMed Web of Science ®Google Scholar
• Biasucci L. M., Liuzzo G., Grillo R. L. Elevated levels of C‐reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999 Feb 23; 99((7))855–60
   PubMedGoogle Scholar
• Lindahl B. Unstable angina & non‐Q wave AMI: hsCRP and Troponin T and long term prognosis. Data from FRISC trial. Circulation 1999; 100 Suppl.I
   Google Scholar
• Morrow D. A., Rifai N., Antman E. M. C‐reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998; 31: 1460–5
   PubMed Web of Science ®Google Scholar
• Omland T., Persson A., Ng L. N‐terminal pro‐B‐type natriuretic peptide and long‐term mortality in acute coronary syndromes. Circulation 2002; 106: 2913–8
   PubMed Web of Science ®Google Scholar
• De lemos J. A., Morrow D. A., Bentley J. H. The prognostic value of B‐type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014–21
   PubMed Web of Science ®Google Scholar
• Jernberg T., Stridsberg M., Venge P., Lindahl B. N‐terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST‐segment elevation. J Am Coll Cardiol 2002; 40: 437–45
   PubMed Web of Science ®Google Scholar
• Baldus S., Heeschen C., Meinertz T. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440–5
   PubMed Web of Science ®Google Scholar
• Sabatine M. S., Morrow D. A., De lemos J. A. Multimarker approach to risk stratification in non‐ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C‐reactive protein, and B‐type natriuretic peptide. Circulation 2002; 105: 1760–3
   PubMed Web of Science ®Google Scholar
• Mega J. L., Morrow D. A., De lemos J. A. B‐type natriuretic peptide at presentation and prognosis in patients with ST‐segment elevation myocardial infarction: an ENTIRE‐TIMI‐23 substudy. J Am Coll Cardiol 2004; 44: 335–9
   PubMed Web of Science ®Google Scholar
• Heeschen C., Hamm C. W., Mitronic V., Lantelme N. H., White H. D., Platelet Receptor Inhibition in Ischemic Syndrome management (PRISM). N‐terminal pro‐B‐type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206–12
   PubMed Web of Science ®Google Scholar
• Heeschen C., Dimmeler S., Hamm C. W., Fichtlscherer S., Simoons M. L., Zeiher A. M., CAPTURE Study Investigators. Pregnancy‐associated plasma protein‐A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005; 45: 229–37
   PubMed Web of Science ®Google Scholar
• Morrow D. A., De lemos J. A., Sabatine M. S. Evaluation of B‐type natriuretic peptide for risk assessment in unstable angina/non‐ST‐elevation myocardial infarction: B‐type natriuretic peptide and prognosis in TACTICS‐TIMI 18. J Am Coll Cardiol 2003; 41: 1264–72
   PubMed Web of Science ®Google Scholar